2 Biotech Stocks Trying to Double Today

PhaseBio and Dermira both reported upbeat drug data

Managing Editor
Mar 18, 2019 at 10:22 AM
facebook X logo linkedin


Two biotech stocks have nearly doubled in value today, and sit near the top of the Nasdaq. First up, PhaseBio Pharmaceuticals Inc (NASDAQ:PHAS) is up 75.3% to trade at $6.52, and earlier nabbed a record high of $8.88 -- more than double Friday's close of $3.72 -- after the company's appearance at the American College of Cardiology (ACC) conference this weekend. Specifically, PhaseBio's new data on its PB2452 drug were well-received. Mid-stage studies are set to begin later this year. 

This is set to be PHAS' best day ever by a wide margin. The drugmaker is now trading above its October $5 initial public offering (IPO) price for the first time since November.

Now, while the shares are in record-high territory, they have a ways to go to hit their average 12-month price target of $16.67. Echoing that, all four analysts following PHAS shares consider them a "buy" or better already.

Then there's Dermira Inc (NASDAQ:DERM), up 107% to trade at $14.16, and earlier hitting a new annual high of $14.91, after the company's eczema treatment met the main goal of its mid-stage study. Prior to today, the $9-$10 area had turned away DERM rallies in 2019. Now, the shares are on track to topple their 320-day moving average for the first time since January 2018, before a massive March bear gap. 

A short squeeze could provide more tailwinds for the equity. More than 10% of DERM's total available float is sold short, and it would take nearly a week for shorts to buy back their bearish bets, at the security's average pace of trading. 

There's been similar skepticism among options traders, judging by the security's Schaeffer's put/call open interest ratio (SOIR) of 1.00, which ranks 5 percentage points from an annual high. This shows a stronger-than-usual put-skew among near-term speculators. An exodus of option bears could also bee a boon for DERM.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI